Scientific Committee Members of Phage Therapy 2024
Ms. Barbara Brenner, Kanzlei BRENNER, Germany |
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy |
||
Prof. Martha Clokie, Editor in Chief of PHAGE Journal, University of Leicester, United Kingdom |
Dr. Daniel De Vos, |
||
Dr. Mariagrazia Di Luca,
|
Prof. Marvin Edeas, |
||
Dr. Ekaterina Chernevskaya, Federal research and clinical center of intensive care medicine and rehabilitology, Russia |
Dr. Cara Fiore, |
||
Dr. Anders Nilsson, |
Dr. Jean-Paul Pirnay, |
||
Dr. Anna Pistocchi, |
Dr. Brieuc Van Nieuwenhuyse, |
||
Prof. William Summers, |
Scientific Committee Members of Phage Therapy 2024
Ms. Barbara Brenner, Kanzlei BRENNER, Germany |
|
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy |
|
Prof. Martha Clokie, Editor in Chief of PHAGE Journal, University of Leicester, United Kingdom |
|
Dr. Daniel De Vos, Queen Astrid Military Hospital, Belgium |
|
Dr. Mariagrazia Di Luca, University of Pisa, Italy |
|
Prof. Marvin Edeas, INSERM – Institut Cochin, Université de Paris, France |
|
Dr. Ekaterina Chernevskaya, |
|
Dr. Cara Fiore, Food and Drug Administration (FDA), USA |
|
Dr. Anders Nilsson, Stockholm University, Sweden |
|
Dr. Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium |
|
Dr. Anna Pistocchi, Università degli Studi di Milano, Italy |
|
Prof. Ben Raymond, University of Exeter, United Kingdom |
|
Prof. William Summers, Retired Professor at Yale University, USA |
|
Dr. Brieuc Van Nieuwenhuyse, UCLouvain, Belgium |